CRSPCAUTIOUS

CRSP Revenue Growth (YoY) Analysis

68.6%

Higher than 96% of Healthcare sector peers

Updated 2555h ago·SEC filings & market data

Key Takeaway

CRISPR Therapeutics’ revenue growth (year-over-year, or YoY) of 68.6% means the company generated 68.6% more revenue in the most recent quarter compared to the same quarter one year ago.

Sector Performance

96th percentile

CRSP

68.6%

Sector Median

8.9%

Sector Avg

12.2%

📊

Deep Analysis

CRISPR Therapeutics’ revenue growth (year-over-year, or YoY) of 68.6% means the company generated 68.6% more revenue in the most recent quarter compared to the same quarter one year ago.

Within the Healthcare sector, the median revenue growth is 6.2%, placing CRISPR in the 98th percentile among sector peers — far above the typical company. The trend analysis is limited: the year-over-year change and quarter-over-quarter change are both listed as N/A, and only a single historical value of 68.6% is available, so no directional pattern can be assessed. The combination of an exceptionally high revenue growth level with no trend data creates a mixed picture — the strong growth signals a positive opportunity, but the absence of a confirmed trend increases uncertainty about sustainability. This metric supports the overall NEUTRAL verdict because the standout level of growth is offset by insufficient information to gauge momentum, making a cautious stance appropriate.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about CRSP?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

How does CRSP's Revenue Growth (YoY) compare to its sector?

CRSP's Revenue Growth (YoY) of 68.6% compares to a Healthcare sector median of 8.9%, placing it in the 96th percentile.

Who are CRSP's closest peers by Revenue Growth (YoY)?

The closest Healthcare peers by Revenue Growth (YoY) include: A (10.0%), ABT (7.8%), DGX (10.2%), RVTY (7.0%), CAH (11.0%).

📚

Learn More About Revenue Growth (YoY)

How to Analyze Revenue Growth: More Than Just Rising Sales

Learn how to analyze revenue growth beyond the headline number. Master absolute vs percentage, YoY vs QoQ, and sustainable growth with real examples from NVDA, GOOGL, and MDB.

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.